Beneficial effects of striatal restoration of CYP46A1 expression using AAVrh10 serotype in Huntington's disease mice model (R6/2)

Archive ouverte

Planques, Anabelle | Hu, Amelie | Piguet, Francoise | Moumne, Lara | Djelti, Fathia | Mailly, Philippe | Cartier, Nathalie | Aubourg, Patrick | Caboche, Jocelyne | Betuing, Sandrine

Edité par CCSD ; Mary Ann Liebert -

Collaborative Congress of the European-Society-of-Gene-and-Cell-Therapy/French-Society-of-Cell-and-Gen e-Therapy, Versailles, FRANCE, OCT 25-29, 2012. International audience. no abstract

Consulter en ligne

Suggestions

Du même auteur

CYP46A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntington’s disease

Archive ouverte | Boussicault, Lydie | CCSD

International audience. Huntington’s disease is an autosomal dominant neurodegenerative disease caused by abnormal polyglutamine expansion in huntingtin (Exp-HTT) leading to degeneration of striatal neurons. Altered...

Mitogen and Stress-activated Kinase-1 deficiency and transcriptional dysregulation in Huntington's Disease

Archive ouverte | Moumne, Lara | CCSD

Collaborative Congress of the European-Society-of-Gene-and-Cell-Therapy/French-Society-of-Cell-and-Gen e-Therapy, Versailles, FRANCE, OCT 25-29, 2012. International audience. no abstract

Multiple aspects of gene dysregulation Huntington's disease

Archive ouverte | Caboche, Jocelyne | CCSD

International audience. Huntington's Disease (HD) is a genetic neurodegenerative disease caused by a CAG expansion in the gene encoding Huntingtin (Htt). It is characterized by chorea, cognitive, and psychiatric dis...

Chargement des enrichissements...